Technical Analysis for HZNP - Horizon Pharma, Inc.

Grade Last Price % Change Price Change
grade B 25.83 -4.19% -1.13
HZNP closed down 4.19 percent on Friday, May 17, 2019, on 87 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical HZNP trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Cup with Handle Other 0.00%
50 DMA Support Bullish -4.19%
Cup with Handle Other -4.19%
NR7 Range Contraction -4.19%
20 DMA Support Bullish -3.11%
50 DMA Support Bullish -3.11%

Older signals for HZNP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company offers DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications. It also provides LODOTRA/RAYOS, a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe active rheumatoid arthritis in adults when accompanied by morning stiffness, as well as approved for the treatment of polymyalgia rheumatica, psoriatic arthritis, ankylosing spondylitis, asthma, chronic obstructive pulmonary disease, and other conditions. The company was founded in 2005 and is headquartered in Deerfield, Illinois.
Medicine Health Pharmaceutical Pain Autoimmune Diseases Rheumatoid Arthritis Asthma Osteoarthritis Inflammatory Diseases Arthritis Chronic Obstructive Pulmonary Disease Rheumatology Psoriatic Arthritis
Is HZNP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.44
52 Week Low 14.89
Average Volume 1,480,099
200-Day Moving Average 22.0803
50-Day Moving Average 26.6394
20-Day Moving Average 26.423
10-Day Moving Average 27.24
Average True Range 1.1541
ADX 17.08
+DI 21.0473
-DI 24.4408
Chandelier Exit (Long, 3 ATRs ) 25.8077
Chandelier Exit (Short, 3 ATRs ) 27.5823
Upper Bollinger Band 28.5443
Lower Bollinger Band 24.3017
Percent B (%b) 0.36
BandWidth 16.056466
MACD Line 0.2008
MACD Signal Line 0.2658
MACD Histogram -0.065
Fundamentals Value
Market Cap 4.22 Billion
Num Shares 163 Million
EPS -2.70
Price-to-Earnings (P/E) Ratio -9.57
Price-to-Sales 2.16
Price-to-Book 2.16
PEG Ratio 0.99
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.59
Resistance 3 (R3) 27.74 27.31 27.29
Resistance 2 (R2) 27.31 26.86 27.23 27.19
Resistance 1 (R1) 26.57 26.59 26.36 26.42 27.10
Pivot Point 26.14 26.14 26.03 26.06 26.14
Support 1 (S1) 25.40 25.69 25.19 25.25 24.56
Support 2 (S2) 24.97 25.42 24.89 24.47
Support 3 (S3) 24.23 24.97 24.37
Support 4 (S4) 24.08